Cite
HARVARD Citation
El‐Adl, K. et al. (2021). Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2, 4‐dichloro)benzylidene]thiazolidine‐2, 4‐dione derivatives as VEGFR‐2 inhibitors. Archiv der Pharmazie. 354 (2), p. n/a. [Online].